Skip to main content

Table 4 Institutional factors associated with the number of patients enrolled per year (multivariate linear mixed model)

From: Improving access to care in low and middle-income countries: institutional factors related to enrollment and patient outcome in a cancer drug access program

 

All institutions (N = 4,946 patients)

 

β

p-value

CI 95%

Year

11.91

<10-4

[5.90; 17.93]

Interactions

   

Year*public

2.08

0.93

[-42.92; 47.08]

Year*hematologist or oncologist

6.12

0.02

[0.98; 11.27]

Year*research

-2.59

0.13

[-5.94; 0.75]

Year*bone aspiration

-8.78

<10-4

[-12.89; -4.66]

Year*Europe

0.00 (ref)

  

Year*SE Asia

3.04

0.34

[-3.24; 9.33]

Year*East Africa

-0.59

0.78

[-4.86;3.67]

Year*West Africa

-11.49

<10-4

[-15.53; -7.45]

Year*Pacific/America

-14.66

<10-4

[-19.54; -9.77]

  1. Results in bold are statistically significant at the 5% level.